2019
DOI: 10.1080/09546634.2019.1568380
|View full text |Cite
|
Sign up to set email alerts
|

Stevens Johnson syndrome and toxic epidermal necrolysis – an Australian analysis of treatment outcomes and mortality

Abstract: Johnson syndrome and toxic epidermal necrolysisan Australian analysis of treatment outcomes and mortalityArticle no: IJDT_A_1568380 Enclosures: 1) Query sheet 2) Article proofs 4. Funding: Was your research for this article funded by a funding agency? If so, please insert `This work was supported by ', followed by the grant number in square brackets `[grant number xxxx]'. 5. Supplemental data and underlying research materials: Do you wish to include the location o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
14
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(17 citation statements)
references
References 23 publications
2
14
0
1
Order By: Relevance
“…The overall mortality rate in our study, 21%, is comparable to those of other retrospective studies 14 during hospitalization. Although those who passed away during hospitalization were all from the first time period studied, our small sample size limits us in any meaningful conclusions between the reasons for the mortality difference between the 2 time periods.…”
Section: Discussionsupporting
confidence: 88%
See 4 more Smart Citations
“…The overall mortality rate in our study, 21%, is comparable to those of other retrospective studies 14 during hospitalization. Although those who passed away during hospitalization were all from the first time period studied, our small sample size limits us in any meaningful conclusions between the reasons for the mortality difference between the 2 time periods.…”
Section: Discussionsupporting
confidence: 88%
“…Our most common offending medications were similar to those of other retrospective studies, with the most common being allopurinol, carbamazepine, cephalosporins, and trimethoprim-sulfamethoxazole. [14][15][16]19 The overall mortality rate in our study, 21%, is comparable to those of other retrospective studies 14 during hospitalization. Although those who passed away during hospitalization were all from the first time period studied, our small sample size limits us in any meaningful conclusions between the reasons for the mortality difference between the 2 time periods.…”
Section: Discussionsupporting
confidence: 87%
See 3 more Smart Citations